User profiles for Ioannis Karakikes

Ioannis Karakikes

Stanford University
Verified email at stanford.edu
Cited by 5493

Human induced pluripotent stem cell–derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes

I Karakikes, M Ameen, V Termglinchan… - Circulation research, 2015 - Am Heart Assoc
Disease models are essential for understanding cardiovascular disease pathogenesis and
developing new therapeutics. The human induced pluripotent stem cell (iPSC) technology …

Therapeutic Cardiac‐Targeted Delivery of miR‐1 Reverses Pressure Overload–Induced Cardiac Hypertrophy and Attenuates Pathological Remodeling

I Karakikes, AH Chaanine, S Kang… - Journal of the …, 2013 - Am Heart Assoc
Background Micro RNA s (mi RNA s) play a key role in the development of heart failure, and
recent studies have shown that the muscle‐specific miR‐1 is a key regulator of cardiac …

[HTML][HTML] Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy

I Karakikes, F Stillitano, M Nonnenmacher… - Nature …, 2015 - nature.com
A number of genetic mutations is associated with cardiomyopathies. A mutation in the coding
region of the phospholamban (PLN) gene (R14del) is identified in families with hereditary …

[HTML][HTML] Acute β-adrenergic overload produces myocyte damage through calcium leakage from the ryanodine receptor 2 but spares cardiac stem cells

GM Ellison, D Torella, I Karakikes… - Journal of Biological …, 2007 - ASBMB
A hyperadrenergic state is a seminal aspect of chronic heart failure. Also, "Takotsubo stress
cardiomyopathy," is associated with increased plasma catecholamine levels. The …

Small molecule-mediated directed differentiation of human embryonic stem cells toward ventricular cardiomyocytes

I Karakikes, GD Senyei, J Hansen… - Stem cells …, 2014 - academic.oup.com
Ioannis Karakikes , Ioannis Karakikes … Correspondence: Ioannis Karakikes, Ph.D., Stanford
University School of Medicine, Stanford Cardiovascular Institute, 300 Campus Drive, Grant …

[PDF][PDF] Patient-specific iPSC-derived endothelial cells uncover pathways that protect against pulmonary hypertension in BMPR2 mutation carriers

…, S Sa, D Li, V Termglinchan, M Ameen, I Karakikes… - Cell stem cell, 2017 - cell.com
In familial pulmonary arterial hypertension (FPAH), the autosomal dominant disease-causing
BMPR2 mutation is only 20% penetrant, suggesting that genetic variation provides …

[HTML][HTML] Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium

IC Turnbull, I Karakikes, GW Serrao, P Backeris… - The FASEB …, 2014 - ncbi.nlm.nih.gov
Cardiac experimental biology and translational research would benefit from an in vitro surrogate
for human heart muscle. This study investigated structural and functional properties and …

iPSC-derived cardiomyocytes reveal abnormal TGF-β signalling in left ventricular non-compaction cardiomyopathy

…, P Shukla, OJ Abilez, JM Churko, I Karakikes… - Nature cell …, 2016 - nature.com
Left ventricular non-compaction (LVNC) is the third most prevalent cardiomyopathy in children
and its pathogenesis has been associated with the developmental defect of the embryonic …

[PDF][PDF] Transcriptome profiling of patient-specific human iPSC-cardiomyocytes predicts individual drug safety and efficacy responses in vitro

…, N Shao, NA Woo, AS Chao, JD Gold, I Karakikes… - Cell stem cell, 2016 - cell.com
Understanding individual susceptibility to drug-induced cardiotoxicity is key to improving
patient safety and preventing drug attrition. Human induced pluripotent stem cells (hiPSCs) …

Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy

…, T Chour, PJ Wang, MP Snyder, HY Chang, I Karakikes… - Nature, 2019 - nature.com
Lamin A/C (LMNA) is one of the most frequently mutated genes associated with dilated
cardiomyopathy (DCM). DCM related to mutations in LMNA is a common inherited …